BioWorld MedTech

May 19, 2016

Short-term results blur promise of healing with Abbott's Absorb stent

PARIS – The question was projected onto a big screen almost as soon as the presentations began for results from registries on the Absorb Bioresorbable Vascular Scaffold (BVS) from Abbott Vascular, based in Abbott Park, Ill. Read More

Medtronic to buy Smith & Nephew's gynecology business for $350M

Mazor shines after inking spine solutions deal with Medtronic

Fosun makes play for India firm Gland Pharma

FDA approves Genentech's immunotherapy duo Tecentriq + diagnostic for bladder cancer

CMS cites availability in DME non-bidding areas as suspension bills in play

Appointments and advancements

Product briefs

Financings

MDD's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 27, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...